Sonoma Pharmaceuticals (SNOA) Enterprise Value (2010 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly Enterprise Value came in at -$2.4 million in Q1 2026, up 55.36% year-on-year from -$1.5 million in Q1 2025, and up 6.33% quarter-over-quarter from -$2.6 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Enterprise Value (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Enterprise Value history runs 17 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- On a quarterly basis, Enterprise Value rose 55.36% year-over-year to -$2.4 million in Q1 2026; TTM through Mar 2026 was -$2.4 million, a 55.36% increase from a year earlier, with the FY2026 full-year figure at -$2.4 million, up 55.36% from the prior year.
- Enterprise Value climbed to -$2.4 million in Q1 2026 per SNOA's latest filing, from -$2.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.1 million in Q3 2023 and bottomed at -$7.4 million in Q1 2022.
- The 5-year median for Enterprise Value is -$3.4 million (2022), against an average of -$3.7 million.
- Across the five-year window, Enterprise Value surged 69.12% in 2022 and sank 117.62% in 2024, its largest moves.
- Year by year, Enterprise Value stood at -$2.6 million in 2022, then rose by 8.66% to -$2.4 million in 2023, then slumped by 117.62% to -$5.2 million in 2024, then surged by 51.09% to -$2.6 million in 2025, then climbed by 6.33% to -$2.4 million in 2026.
- Per Business Quant, the three latest SNOA Enterprise Value figures stand at -$2.4 million (Q1 2026), -$2.6 million (Q4 2025), and -$3.0 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | -2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.40 Mn |
| Dec 31, 2025 | -2.56 Mn |
| Sep 30, 2025 | -3.04 Mn |
| Jun 30, 2025 | -3.61 Mn |
| Mar 31, 2025 | -5.37 Mn |
| Dec 31, 2024 | -5.24 Mn |
| Sep 30, 2024 | -4.08 Mn |
| Jun 30, 2024 | -2.59 Mn |
| Mar 31, 2024 | -3.13 Mn |
| Dec 31, 2023 | -2.41 Mn |
| Sep 30, 2023 | -2.14 Mn |
| Jun 30, 2023 | -3.54 Mn |
| Mar 31, 2023 | -3.82 Mn |
| Dec 31, 2022 | -2.63 Mn |
| Sep 30, 2022 | -3.35 Mn |
| Jun 30, 2022 | -5.59 Mn |
| Mar 31, 2022 | -7.40 Mn |
| Dec 31, 2021 | -8.53 Mn |
| Sep 30, 2021 | -8.39 Mn |
| Jun 30, 2021 | -2.81 Mn |